13F Filings for Deep Track Capital, LP (CIK: 1856083)
View the most recent portfolio holdings disclosed by Deep Track Capital, LP in their 13F filing.
| Holding | Shares | Value | Portfolio Percent | Change Status | Change Amount |
|---|---|---|---|---|---|
| GH - GUARDANT HEALTH INC(Class: COM) | 4.25M | $221.17M | 7.09% | Decreased | 1.19M (21.0%, $10.73M) |
| IONS - IONIS PHARMACEUTICALS INC(Class: COM) | 4.89M | $193.26M | 6.20% | Increased | 327.34K (7.0%, $55.56M) |
| PTGX - PROTAGONIST THERAPEUTICS INC(Class: COM) | 3.25M | $179.40M | 5.75% | Increased | 245.90K (8.0%, $34.32M) |
| DVAX - DYNAVAX TECHNOLOGIES CORP(Class: COM NEW) | 17.79M | $176.49M | 5.66% | Unchanged | |
| INSM - INSMED INC(Class: COM PAR $.01) | 1.75M | $176.12M | 5.65% | Increased | 1.50M (586.0%, $156.69M) |
| AKRO - AKERO THERAPEUTICS INC(Class: COM) | 3.04M | $162.35M | 5.21% | Decreased | 167.67K (5.0%, $32.40M) |
| IMVT - IMMUNOVANT INC(Class: COM) | 9.50M | $152M | 4.87% | Unchanged | |
| OCUL - OCULAR THERAPEUTIX INC(Class: COM) | 14.29M | $132.65M | 4.25% | Unchanged | |
| APLS - APELLIS PHARMACEUTICALS INC(Class: COM) | 7M | $121.17M | 3.89% | Increased | 2M (40.0%, $11.82M) |
| CYTK - CYTOKINETICS INC(Class: COM NEW) | 3.65M | $120.60M | 3.87% | Increased | 576.15K (18.0%, $2.94M) |
| GPCR - STRUCTURE THERAPEUTICS INC(Class: SPONSORED ADS) | 5.13M | $106.48M | 3.41% | Increased | 1.03M (25.0%, $35.51M) |
| ETNB - 89BIO INC(Class: COM) | 9.50M | $93.29M | 2.99% | Increased | 183.67K (1.0%, $25.56M) |
| AXSM - AXSOME THERAPEUTICS INC(Class: COM) | 801.37K | $83.66M | 2.68% | New | 801.37K ($83.66M) |
| VRDN - VIRIDIAN THERAPEUTICS INC(Class: COM) | 5.38M | $75.22M | 2.41% | Unchanged | |
| TARS - TARSUS PHARMACEUTICALS INC(Class: COM) | 1.75M | $70.89M | 2.27% | Increased | 265.73K (17.0%, $5.35M) |
| PCVX - VAXCYTE INC(Class: COM) | 2.15M | $69.90M | 2.24% | Increased | 1.40M (186.0%, $41.58M) |
| NRIX - NURIX THERAPEUTICS INC(Class: COM) | 6.06M | $69.08M | 2.22% | Increased | 564.91K (10.0%, $3.74M) |
| GERN - GERON CORP(Class: COM) | 43M | $60.63M | 1.94% | Increased | 4.82M (12.0%, $70.24K) |
| IMCR - IMMUNOCORE HLDGS PLC(Class: ADS) | 1.80M | $56.48M | 1.81% | Increased | 388.60K (27.0%, $14.61M) |
| RARE - ULTRAGENYX PHARMACEUTICAL IN(Class: COM) | 1.35M | $49.09M | 1.57% | Unchanged | |
| MAZE - MAZE THERAPEUTICS INC(Class: COM) | 3.95M | $48.45M | 1.55% | Increased | 679.78K (20.0%, $12.46M) |
| ANIP - ANI PHARMACEUTICALS INC(Class: COM) | 700K | $45.67M | 1.46% | Unchanged | |
| XENE - XENON PHARMACEUTICALS INC(Class: COM) | 1.35M | $42.26M | 1.36% | Increased | 350K (35.0%, $8.71M) |
| DNTH - DIANTHUS THERAPEUTICS INC(Class: COM) | 2.23M | $41.60M | 1.33% | Decreased | 124.55K (5.0%, $1.17M) |
| CLDX - CELLDEX THERAPEUTICS INC NEW(Class: COM NEW) | 2M | $40.70M | 1.31% | Unchanged |